[Hematopoietic stem cells transplant in patients with common variable immunodeficiency. Is a therapeutic option?]

[Hematopoietic stem cells transplant in patients with common variable immunodeficiency. Is a therapeutic option?]

Rev Alerg Mex. 2017 Jan-Mar;64(1):121-125

Authors: Cambray-Gutiérrez JC, Herrera-Sánchez DA, López-Pérez P, Chávez-García A, Yamazaki-Nakashimada MA

Abstract
BACKGROUND: Patients with common variable immunodeficiency show higher incidence of sinopulmonary and gastrointestinal infections, as well as lymphoproliferative and autoimmune diseases. The treatment of choice is replacement therapy with human gamma-globulin. Hematopoietic stem cell transplantation is a non-conventional therapeutic modality.
CASE REPORT: Twenty-six-year old woman with no family or hereditary history of primary immune deficiencies or consanguinity, with repeated episodes of otitis, sinusitis, gastroenteritis and bronchitis since childhood. At adolescence, she was diagnosed with common variable immunodeficiency; she was prescribed intravenous gamma-globulin, broad-spectrum antimicrobials and macrolides. At 22 years of age, she underwent hematopoietic stem cell transplantation owing to continued severe infections. At 4 months, post-transplantation she was diagnosed with hypothyroidism and ovarian insufficiency. During the following 3 years, she had no infections, but at 25 years of age she had immune thrombocytopenic purpura diagnosed, which persists together with Raynaud's disease and upper respiratory tract persistent infections. At the moment of this report she is being treated with intravenous gamma-globulin and receiving prophylaxis with clarithromycin, without steroids or danazol.
CONCLUSIONS: Given the high rate of morbidity and mortality associated and immune reconstitution failure, hematopoietic stem cell transplantation should be carefully evaluated in patients with treatment-unresponsive infections or lymphoproliferative disorders.

PMID: 28188718 [PubMed - in process]

http://ift.tt/2lA1tQZ